Chesnara (CSN) M&A announcement summary
Event summary combining transcript, slides, and related documents.
M&A announcement summary
17 Feb, 2026Deal rationale and strategic fit
Acquisition expands presence in Luxembourg, a stable, AAA-rated market, supporting ambitions to be a leading European life and pensions consolidator and providing a platform for future cross-border consolidation.
Adds a scalable platform with 46,000 policies and €1.7 billion in assets under administration, supporting further European expansion.
Scottish Widows Europe’s closed life and pensions business aligns with existing expertise and product familiarity, with the experienced management team remaining post-acquisition.
Enhances group scale and strengthens position in Europe, with a modern, scalable operating platform.
Supports strategy of value-enhancing M&A and positions the group as a leading European consolidator.
Financial terms and conditions
Total consideration is €110 million, representing 64% of Scottish Widows Europe’s eligible own funds.
Funded entirely from available cash, including proceeds from a recent RT1 issuance, with no external fundraising required.
Pro-forma solvency coverage ratio remains strong at 173%, above the 140%-160% target range, and leverage below 30%.
Expected incremental cash generation of €250 million over the lifetime of the acquired policies, with €100 million in the first five years.
Deal is expected to be materially value accretive at completion.
Synergies and expected cost savings
Modern, efficient, and scalable platform enables operational leverage and supports future growth.
Policy administration powered by a leading third-party technology provider (Lifeware), supporting efficiency.
Structural synergies from increased group size and risk diversification across territories.
Opportunity to extend proven capital management actions, such as reinsurance and hedging, to the new portfolio.
Additional upside possible from late-stage integration synergies not yet included in disclosed numbers.
Latest events from Chesnara
- Simplified metrics highlight sustainable capital and profit, enhancing transparency and comparability.CSN
Investor presentation16 Mar 2026 - Strong cash generation, 3% dividend rise, and 201% solvency with active M&A pipeline.CSN
H1 20243 Feb 2026 - Cash generation up 14%, solvency at 203%, and dividend up 3% with strong M&A momentum.CSN
H2 202426 Dec 2025 - £37m cash generation, 207% solvency, and HSBC Life (UK) acquisition drive growth.CSN
H1 202523 Nov 2025 - £260m deal, £140m rights issue, £800m+ cash flow, 6% dividend growth, FTSE 250 target.CSN
M&A Announcement13 Nov 2025